Intracranial mass
(UMLS:C0270614)
- UMLS ID:
- C0270614
- MeSH ID:
- N/A
Synonym(s)
1.
Intracranial mass
2.
Intracranial lump
3.
Mass of intracranial structure
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Rivaroxaban | FAERS: 8 | US FAERS | |
| 2 | Dimethyl Fumarate | FAERS: 6 | US FAERS | |
| 3 | Fingolimod Hydrochloride | FAERS: 6 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 4 | Dabigatran | FAERS: 5 | US FAERS | |
| 5 | Temozolomide | FAERS: 4 | US FAERS | |
| 6 | Insulin Glargine | FAERS: 3 | US FAERS | |
| 7 | Lenalidomide | FAERS: 3 | US FAERS | |
| 8 | Tacrolimus | FAERS: 3 | US FAERS | |
| 9 | Warfarin | FAERS: 3 | US FAERS | |
| 10 | apixaban | FAERS: 3 | US FAERS | |
| 11 | pazopanib | FAERS: 3 | US FAERS | |
| 12 | pomalidomide | FAERS: 3 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 13 | 4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide | FAERS: 2 | US FAERS | |
| 14 | Axitinib | FAERS: 2 | US FAERS | |
| 15 | Lapatinib | FAERS: 2 | US FAERS | |
| 16 | MDV 3100 | FAERS: 2 | US FAERS | |
| 17 | Modafinil | FAERS: 2 | US FAERS | |
| 18 | Norgestrel | FAERS: 2 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 19 | Octreotide | FAERS: 2 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 20 | Sildenafil Citrate | FAERS: 2 | US FAERS | |
| 21 | carfilzomib | FAERS: 2 | US FAERS | |
| 22 | osimertinib | FAERS: 2 | US FAERS | |
| 23 | palbociclib | FAERS: 2 | US FAERS | |
| 24 | ponatinib | FAERS: 2 | US FAERS | |
| 25 | treprostinil | FAERS: 2 | US FAERS | |
| 26 | 4-Aminopyridine | FAERS: 1 | US FAERS | |
| 27 | AP26113 | FAERS: 1 | US FAERS | |
| 28 | Arthrotec | FAERS: 1 | US FAERS | |
| 29 | Aspirin | FAERS: 1 | US FAERS | |
| 30 | Atorvastatin | FAERS: 1 | US FAERS | |
| 31 | Carboplatin | FAERS: 1 | US FAERS | |
| 32 | Clobazam | FAERS: 1 Canada Vigilance: 1 | Canada Vigilance US FAERS | |
| 33 | Droxidopa | FAERS: 1 | US FAERS | |
| 34 | Everolimus | FAERS: 1 | US FAERS | |
| 35 | Gefitinib | FAERS: 1 | US FAERS | |
| 36 | Ipratropium | FAERS: 1 | US FAERS | |
| 37 | Memantine | FAERS: 1 | US FAERS | |
| 38 | Mycophenolic Acid | FAERS: 1 | US FAERS | |
| 39 | PCI 32765 | FAERS: 1 | US FAERS | |
| 40 | Paclitaxel | FAERS: 1 | US FAERS | |
| 41 | Ranolazine | FAERS: 1 | US FAERS | |
| 42 | Rifaximin | FAERS: 1 | US FAERS | |
| 43 | Sorafenib | FAERS: 1 | US FAERS | |
| 44 | Ticagrelor | FAERS: 1 | US FAERS | |
| 45 | Valproic Acid | FAERS: 1 | US FAERS | |
| 46 | etonogestrel | FAERS: 1 | US FAERS | |
| 47 | reviparin | FAERS: 1 | US FAERS | |
| 48 | Diane | Canada Vigilance: 1 | Canada Vigilance | |
| 49 | Imatinib Mesylate | Canada Vigilance: 1 | Canada Vigilance | |
| 50 | Octreotide | Canada Vigilance: 1 | Canada Vigilance | |
| 51 | regorafenib | Canada Vigilance: 1 | Canada Vigilance |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.